You are here

diabetes

Novo Nordisk reinforces its commitment to fight 'urban diabetes' for the New Year

Fierce Pharma Marketing

Tue, 01/5/16 - 11:17 am

MannKind Corporation Announces Termination of License and Collaboration Agreement With Sanofi

Yahoo

Tue, 01/5/16 - 09:33 am

inhaled insulin

Eli Lilly Can Save Transition Therapeutics Inc.

Seeking Alpha

Tue, 12/29/15 - 10:50 pm

Transition Therapeutics

Sanofi takes an FDA shortcut with its diabetes combo, racing with Novo

Fierce Biotech

Wed, 12/23/15 - 09:34 pm

Sanofi Gains on New Drug Application

Bidness, ETC

Wed, 12/23/15 - 11:13 am

insulin glargine

Lilly gets its Lantus copycat Basaglar approved by FDA—but not as a biosimilar

BioPharma Dive

Thu, 12/17/15 - 02:00 pm

FDA approves cheaper version of top-selling diabetes drug

Yahoo/Reuters

Wed, 12/16/15 - 07:56 pm

Boehringer Ingelheim

Novo Nordisk eyes stepped-up diabetes care in 'beyond the pill' deal with IBM Watson

Fierce Pharma Marketing

Mon, 12/14/15 - 10:34 pm

Will Anyone Catch MannKind's Hail Mary?

Motley Fool

Mon, 12/14/15 - 09:58 am

Is MannKind Corporation in a Death Spiral?

Motley Fool

Thu, 12/10/15 - 10:06 am

Lilly's next-gen insulin hopes hit a buzzsaw as firm ditches late-stage diabetes candidate

BioPharma Dive

Mon, 12/7/15 - 03:00 pm

Lilly stops development of diabetes treatment

Yahoo/Reuters

Fri, 12/4/15 - 01:55 pm

Novo Nordisk's First Diabetes Pill Could Be A $10-20 Billion Super-Blockbuster

Seeking Alpha

Fri, 11/27/15 - 11:59 am

Novo Nordisk's PIONEER Trial Will Establish A New Frontier In Oral Anti-Diabetics

Seeking Alpha

Sat, 11/21/15 - 12:28 pm

MannKind's Desperation Move Comes Up Short -- Now What?

Motley Fool

Thu, 11/19/15 - 04:44 pm

Diabetes: Fractyl Labs closes $57m Series C round

Mass Device

Thu, 11/19/15 - 01:20 pm

Drug makers beat diabetes lawsuits with an unusual ruling

Pharmalot

Fri, 11/13/15 - 08:49 pm

Why MannKind Corporation Is Soaring Today

Motley Fool

Thu, 11/12/15 - 01:43 pm

Januvia and Janumet: Merck’s Blockbuster Diabetes Products

Yahoo/Market Realist

Thu, 11/12/15 - 09:19 am

GSK shoots for diabetes-esque platform approach with new respiratory med in hand

Fierce Pharma Marketing

Wed, 11/11/15 - 09:18 pm

Pages